Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 8-K Event Other events
  2. 8-K Event Other events
  3. 8-K Event Other events
  4. 4 Open-market sale Chief Executive Officer sold 125,309 shares at an average $132.34 ($16,583,634)
  5. 4 Open-market sale Chief Executive Officer sold 83,359 shares at an average $182.37 ($15,202,048)
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations · Other events
  8. 8-K Event Other events
  9. 8-K Event Results of operations
  10. 4 Open-market sale Chief Executive Officer sold 69,216 shares at an average $71.82 ($4,971,360)
  11. 4 Open-market sale Chief Executive Officer sold 70,855 shares at an average $152.13 ($10,778,877)
  12. 8-K Event Regulation FD disclosure
  13. 4 Open-market sale CMO, Hematology sold 21,000 shares at an average $332.42 ($6,980,771)
  14. 8-K Event Other events
  15. 4 Open-market sale Chief Executive Officer sold 67,481 shares at an average $94.83 ($6,399,303)
  16. 4 Open-market sale Chief Executive Officer sold 123,821 shares at an average $117.22 ($14,514,637)
  17. 4 Open-market sale President, COO & GM China sold 10,180 shares at an average $325.53 ($3,313,927)
  18. 4 Open-market sale Director sold 4,848 shares at an average $348.15 ($1,687,852)
  19. 4 Open-market sale Chief Financial Officer sold 308 shares at $349.06 ($107,512)
  20. 3 Insider Initial Statement of Ownership

Page 34 of 64 · 1,278 filings